Nano Holdings,Inc.

ＮＡＮＯホールディングス

Industry: Pharmaceutical
Market: Growth
Accounting standards: Japanese GAAP
Consolidation basis: Consolidated

Notes

Consolidation basis
Consolidated / Since Mar 2023

Key metrics

Revenue(thousand JPY)

Mar 2021

313,264

Mar 2022

264,032

Mar 2023

202,189

Mar 2024

135,508

Mar 2025

108,516

Operating profit(thousand JPY)

Mar 2021

-1,302,882

Mar 2022

-2,061,088

Mar 2023

-1,246,000

Mar 2024

-864,415

Mar 2025

-755,349

Operating profit margin(%)

Mar 2021

-415.91

Mar 2022

-780.62

Mar 2023

-616.26

Mar 2024

-637.91

Mar 2025

-696.07

Profit before tax(thousand JPY)

Mar 2021

-2,832,027

Mar 2022

-1,879,056

Mar 2023

-1,308,486

Mar 2024

-777,512

Mar 2025

-832,594

Profit(thousand JPY)

Mar 2021

-2,835,793

Mar 2022

-1,881,678

Mar 2023

-1,310,976

Mar 2024

-780,002

Mar 2025

-835,380

Total assets(thousand JPY)

Mar 2021

7,820,968

Mar 2022

7,136,247

Mar 2023

5,784,390

Mar 2024

5,071,279

Mar 2025

3,996,884

Cash and cash equivalents(thousand JPY)

Mar 2021

1,891,799

Mar 2022

1,097,044

Mar 2023

1,309,592

Mar 2024

1,575,263

Mar 2025

1,197,201

Cash flows from operating activities(thousand JPY)

Mar 2021

-1,247,432

Mar 2022

-1,752,992

Mar 2023

-1,087,051

Mar 2024

-585,081

Mar 2025

-401,617

Cash flows from investing activities(thousand JPY)

Mar 2021

-871,694

Mar 2022

-244,133

Mar 2023

1,207,913

Mar 2024

793,007

Mar 2025

587,528

Cash flows from financing activities(thousand JPY)

Mar 2021

-11,461

Mar 2022

1,145,835

Mar 2023

Mar 2024

3,728

Mar 2025

-568,775

Return on equity(-)

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Equity ratio(%)

Mar 2021

94.8

Mar 2022

77.6

Mar 2023

73.5

Mar 2024

67.2

Mar 2025

68.2

Earnings per share(JPY per share)

Mar 2021

-41.53

Mar 2022

-26.9

Mar 2023

-18.7

Mar 2024

-11.1

Mar 2025

-11.85

Net assets per share(JPY per share)

Mar 2021

106.13

Mar 2022

79.08

Mar 2023

60.61

Mar 2024

48.39

Mar 2025

38.59

Dividend per share(-)

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Payout ratio(-)

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Disclaimer

The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.

The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.